Aswin Menke

2.2k citations

44 papers · 1.6k indexed · 1 hit paper · h-index 22

Impact in

Epidemiology top 5%
- Liver Disease Diagnosis and Treatment
Endocrinology, Diabetes and Metabolism top 5%
- Diet, Metabolism, and Disease

Papers in ⓘ

Molecular Biology 22
- Renal and related cancers 11
Epidemiology 19
- Liver Disease Diagnosis and Treatment 19

Co-authors: Robert Kleemann (16 shared papers)Anita M. van den Hoek (14 shared papers)Wen Liang (3 shared papers)J. Lindeman (2 shared papers)Louis M. Havekes (2 shared papers)André Wolterbeek (6 shared papers)Reinout Stoop (2 shared papers)Ger H. Koek (1 shared paper)
Journals: The FASEB Journal (4 papers)International Journal of Molecular Sciences (4 papers)Reproductive Toxicology (3 papers)Toxicologic Pathology (2 papers)Heliyon (2 papers)
Partner nations: Netherlands United Kingdom United States

In The Last Decade

Aswin Menke

44 papers receiving 1.6k citations

Hit Papers

align trajectories log scale

Establishment of a General NAFLD Scoring System for Rodent Models and Comparison to Human Liver Pathology 2014 · 438 citations

Peers

Countries citing papers authored by Aswin Menke

Since Specialization

Citations

This map shows the geographic impact of Aswin Menke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aswin Menke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aswin Menke more than expected).

Fields of papers citing papers by Aswin Menke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aswin Menke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aswin Menke. The network helps show where Aswin Menke may publish in the future.

Co-authors

The 25 scholars most cited alongside Aswin Menke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Aswin Menke Line = papers co-authored together Aswin Menke links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Establishment of a General NAFLD Scoring System for Rodent Models and Comparison to Human Liver Pathology PLoS ONE ·Wen Liang, Aswin Menke, Ann Driessen, Ger H. Koek, J. Lindeman, Reinout Stoop, Louis M. Havekes, Robert Kleemann, Anita M. van den Hoek Hit paper breakdown →	2014	438
2	Normal Anatomy and Histology of the Adult Zebrafish Toxicologic Pathology ·Aswin Menke, Jan M. Spitsbergen, André Wolterbeek, R.A. Woutersen	2011	173
3	Wilms' tumour gene 1 (WT1) in human neoplasia Leukemia ·Ulrich Keilholz, H. D. Menssen, Alexander Gaiger, Aswin Menke, Yusuke Oji, Yoshitaka Oka, Carmen Scheibenbogen, Hans J. Stauss, E. Thiel, Haruo Sugiyama	2005	74
4	Metabolically induced liver inflammation leads to NASH and differs from LPS- or IL-1β-induced chronic inflammation Laboratory Investigation ·Wen Liang, J. Lindeman, Aswin Menke, Debby P.Y. Koonen, Martine C. Morrison, Louis M. Havekes, Anita M. van den Hoek, Robert Kleemann	2014	72
5	EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity Oncogene ·Volkher Scharnhorst, Aswin Menke, Joline Attema, Johan Klein Haneveld, Nicole Riteco, G.J. van Steenbrugge, Alex J. van der Eb, Aart G. Jochemsen	2000	66
6	Intervention with a caspase-1 inhibitor reduces obesity-associated hyperinsulinemia, non-alcoholic steatohepatitis and hepatic fibrosis in LDLR−/−.Leiden mice International Journal of Obesity ·Martine C. Morrison, Petra Mulder, Kanita Salic, Joanne Verheij, Wen Liang, Wim van Duyvenvoorde, Aswin Menke, T. Kooistra, Robert Kleemann, Peter Y. Wielinga	2016	56
7	Obeticholic Acid Modulates Serum Metabolites and Gene Signatures Characteristic of Human NASH and Attenuates Inflammation and Fibrosis Progression in Ldlr‐/‐.Leiden Mice Hepatology Communications ·Martine C. Morrison, Lars Verschuren, Kanita Salic, Joanne Verheij, Aswin Menke, Peter Y. Wielinga, Marta Iruarrizaga‐Lejarreta, Laurent Golé, Weimiao Yu, Scott Turner, Martien P. M. Caspers, Ibon Martínez‐Arranz, Elsbet Pieterman, Reinout Stoop, Arianne van Koppen, Anita M. van den Hoek, José M. Mato, Roeland Hanemaaijer, Cristina Alonso, Robert Kleemann	2018	53
8	Multiple roles for the Wilms' tumor suppressor, WT1. PubMed ·R. Davies, Adrian W. Moore, Andreas Schedl, Eva Bratt, Kiyoshi Miyahawa, Michael Ladomery, Colin G. Miles, Aswin Menke, Veronica van Heyningen, Nicholas D. Hastie	1999	52
9	The E3 ubiquitin-protein ligase Triad1 inhibits clonogenic growth of primary myeloid progenitor cells Blood ·Jurgen A. Marteijn, Liesbeth van Emst, Claudia Erpelinck-Verschueren, Gorica Nikoloski, Aswin Menke, Théo de Witte, Bob Löwenberg, Joop H. Jansen, Bert A. van der Reijden	2005	44
10	Diet and exercise reduce pre-existing NASH and fibrosis and have additional beneficial effects on the vasculature, adipose tissue and skeletal muscle via organ-crosstalk Metabolism ·Anita M. van den Hoek, Jelle C. B. C. de Jong, Nicole Worms, Anita van Nieuwkoop, M. Voskuilen, Aswin Menke, Serene Lek, Martien P. M. Caspers, Lars Verschuren, Robert Kleemann	2021	38
11	Zebrafish embryotoxicity test for developmental (neuro)toxicity: Demo case of an integrated screening approach system using anti-epileptic drugs Reproductive Toxicology ·Anna Beker van Woudenberg, Cor Snel, Eke Rijkmans, Didima de Groot, Marga Bouma, Sanne A.B. Hermsen, Aldert H. Piersma, Aswin Menke, André Wolterbeek	2014	37
12	A Translational Mouse Model for NASH with Advanced Fibrosis and Atherosclerosis Expressing Key Pathways of Human Pathology Cells ·Anita M. van den Hoek, Lars Verschuren, Nicole Worms, Anita van Nieuwkoop, Christa de Ruiter, Joline Attema, Aswin Menke, Martien P. M. Caspers, Sridhar Radhakrishnan, Kanita Salic, Robert Kleemann	2020	36
13	A category approach to predicting the developmental (neuro) toxicity of organotin compounds: The value of the zebrafish (Danio rerio) embryotoxicity test (ZET) Reproductive Toxicology ·Anna Beker van Woudenberg, André Wolterbeek, Lindsey te Brake, Cor Snel, Aswin Menke, Carina M. Rubingh, Didima de Groot, Dinant Kroese	2013	34
14	The Wilms’ tumor suppressor WT1: Approaches to gene function Kidney International ·Aswin Menke, Lesley McInnes, Nicholas D. Hastie, Andreas Schedl	1998	34
15	Butyrate Protects against Diet-Induced NASH and Liver Fibrosis and Suppresses Specific Non-Canonical TGF-β Signaling Pathways in Human Hepatic Stellate Cells Biomedicines ·Eveline Gart, Wim van Duyvenvoorde, Karin Toet, Martien P. M. Caspers, Lars Verschuren, Mette Juul Nielsen, Diana Julie Leeming, Everton Souto Lima, Aswin Menke, Roeland Hanemaaijer, Jaap Keijer, Kanita Salic, Robert Kleemann, Martine C. Morrison	2021	33
16	The wt1 ‐heterozygous mouse; a model to study the development of glomerular sclerosis The Journal of Pathology ·Aswin Menke, Annemieke IJpenberg, Stewart Fleming, Allyson Ross, Claire N. Medine, C.E. Patek, Lee Spraggon, Jeremy Hughes, Alan R. Clarke, Nicholas D. Hastie	2003	33
17	Abnormal WT1 expression in the CD34‐negative compartment in myelodysplastic bone marrow British Journal of Haematology ·Jeroen P. van Dijk, Gertrudis H. J. N. Knops, L. T. F. Van De Locht, Aswin Menke, Joop H. Jansen, E. J. B. M. Mensink, Reinier Raymakers, Théo de Witte	2002	28
18	Intervention with isoleucine or valine corrects hyperinsulinemia and reduces intrahepatic diacylglycerols, liver steatosis, and inflammation in Ldlr−/−.Leiden mice with manifest obesity‐associated NASH The FASEB Journal ·Eveline Gart, Wim van Duyvenvoorde, Martien P. M. Caspers, Nikki van Trigt, Jessica Snabel, Aswin Menke, Jaap Keijer, Kanita Salic, Martine C. Morrison, Robert Kleemann	2022	24
19	Cholesterol Accumulation as a Driver of Hepatic Inflammation Under Translational Dietary Conditions Can Be Attenuated by a Multicomponent Medicine Frontiers in Endocrinology ·Andrea Mueller, Robert Kleemann, Eveline Gart, Wim van Duyvenvoorde, Lars Verschuren, Martien P. M. Caspers, Aswin Menke, Natascha Krömmelbein, Kanita Salic, Yvonne Burmeister, Bernd Seilheimer, Martine C. Morrison	2021	24
20	Are zebrafish larvae suitable for assessing the hepatotoxicity potential of drug candidates? Journal of Applied Toxicology ·Natalie Mesens, Alexander D. Crawford, Aswin Menke, Pham Duc Hung, Freddy Van Goethem, Rik Nuyts, Erik Hansen, André Wolterbeek, Jacky Van Gompel, Peter de Witte, Camila V. Esguerra	2015	24

About Aswin Menke

Aswin Menke is a scholar working on Molecular Biology, Epidemiology, Physiology, Hepatology and Surgery, having authored 44 papers that have together received 1.6k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (19 papers), Renal and related cancers (11 papers), Diet and metabolism studies (6 papers), Liver Diseases and Immunity (4 papers), Diet, Metabolism, and Disease (4 papers), Zebrafish Biomedical Research Applications (4 papers), Endoplasmic Reticulum Stress and Disease (3 papers) and Hepatitis C virus research (3 papers). The work is most often cited by research in Epidemiology (606 citations), Endocrinology, Diabetes and Metabolism (263 citations), Hepatology (123 citations), Cell Biology (205 citations) and Physiology (300 citations). Aswin Menke has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include Robert Kleemann, Anita M. van den Hoek, Wen Liang, J. Lindeman, Louis M. Havekes, André Wolterbeek, Reinout Stoop, Ger H. Koek, Ann Driessen and R.A. Woutersen. Their work appears in journals such as The FASEB Journal, International Journal of Molecular Sciences, Reproductive Toxicology, Toxicologic Pathology and Heliyon.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact